Log In
BCIQ
Print this Print this
 

Triage Cardiac Panel

  Manage Alerts
Collapse Summary General Information
Company Alere Inc.
DescriptionImmunoassay for the quantitative determination of CK-MB, myoglobin and troponin I in whole blood or plasma
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCardiovascular, Diagnostic
Indication DetailsDiagnose acute myocardial infarction (AMI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$8,400.0M

$5,800.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/01/2016

$8,400.0M

$5,800.0M

0

Get a free BioCentury trial today